{"transactions":[{"id":2702600,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-05-20T16:35:39.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"400,000 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":1581060,"derivative":{"exercise_price":1.7,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069938","document":"tm2117144-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465921069938/tm2117144-4_4seq1.xml","form_type":"4"}},{"id":2849085,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-18T16:05:28.000Z","date":"2021-02-18","kind":"purchase","acquired":true,"shares":10000,"price":2,"value":20000.0,"ownership":{"direct":true},"balance_after":14800,"source":{"system":"sec-edgar","filing":"0001104659-21-025196","document":"tm217063-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465921025196/tm217063-1_4seq1.xml","form_type":"4"}},{"id":2963892,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-30T16:53:23.000Z","date":"2020-11-25","kind":"purchase","acquired":true,"shares":4500,"price":1.62,"value":7290.0,"ownership":{"direct":true},"balance_after":4800,"source":{"system":"sec-edgar","filing":"0001104659-20-130531","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465920130531/a4.xml","form_type":"4"}},{"id":3049653,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-08-21T16:15:29.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":381060,"derivative":{"exercise_price":3.72,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001104659-20-097591","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465920097591/a4.xml","form_type":"4"}},{"id":3180363,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-04-07T16:13:11.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"71,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months."}],"balance_after":221059,"derivative":{"exercise_price":1.63,"expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001104659-20-044168","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465920044168/a4.xml","form_type":"4"}},{"id":3455822,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-07-25T16:16:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 1,940 options shall vest on each of July 24, 2020, 2021 and 2022."}],"balance_after":6059,"derivative":{"exercise_price":3.24,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001104659-19-041851","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465919041851/a4.xml","form_type":"4"}},{"id":3874114,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Warrants","published_at":"2018-07-03T14:17:28.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":8625,"price":1000,"value":8625000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"}],"balance_after":8625,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","expiration_date":"2023-07-03","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-18-043797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465918043797/a4.xml","form_type":"4"}},{"id":3874113,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-07-03T14:17:28.000Z","date":"2018-07-03","kind":"purchase","acquired":true,"shares":15,"price":1000,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $1.55."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series C Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series C Convertible Preferred Stock and 575 Warrants"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series C Convertible Preferred Stock do not expire."}],"balance_after":15,"derivative":{"exercise_price":1.55,"exercise_date":"2018-07-03","underlying":"Common Stock","underlying_shares":9678},"source":{"system":"sec-edgar","filing":"0001104659-18-043797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465918043797/a4.xml","form_type":"4"}},{"id":4105114,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-01-05T13:09:52.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":101221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":167947,"source":{"system":"sec-edgar","filing":"0001104659-18-000925","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465918000925/a4.xml","form_type":"4"}},{"id":4253116,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2017-07-21T16:01:01.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in three installments as follows: 5,000 vest on each of July 20, 2018, 2019 and 2020."}],"balance_after":133688,"derivative":{"exercise_price":0.58,"expiration_date":"2027-07-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-17-046277","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465917046277/a4.xml","form_type":"4"}},{"id":4260719,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2017-07-07T17:01:27.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":46726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan.  All of the shares vested upon grant.  Such shares were issued in lieu of a cash bonus to the reporting person."}],"balance_after":66726,"source":{"system":"sec-edgar","filing":"0001104659-17-044101","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465917044101/a4.xml","form_type":"4"}},{"id":4274254,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":139177,"kind":"person","name":"Cavan John T","position":1,"cik":"0001503738","reported_name":"Cavan John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2017-06-22T09:00:25.000Z","date":"2017-06-20","kind":"purchase","acquired":true,"shares":20000,"price":0.65,"value":13000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-17-040822","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503738/000110465917040822/a4.xml","form_type":"4"}}]}